Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$653K Sell
19,888
-99,716
-83% -$3.44M 0.01% 1013
2017
Q3
$4M Buy
119,604
+44,455
+59% +$1.53M 0.07% 453
2017
Q2
$2.67M Buy
75,149
+62,201
+480% +$2.1M 0.06% 549
2017
Q1
$397K Buy
+12,948
New +$399K 0.01% 1010

Other funds holding QGEN

AHL Partners's QGEN Position: Q4 2017 in Review

AHL Partners reduced its Qiagen (QGEN) stake by 83% in Q4 2017, selling an estimated $3.44M and leaving 19,888 shares worth $653K. The position accounts for 0.01% of the portfolio, ranked #1013.

AHL Partners first reported a position in QGEN in Q1 2017 and has held it in 4 quarters since. The position peaked at $4M in Q3 2017. 215 funds tracked by Wall St. Rank hold QGEN as of Q4 2017.

  • AHL Partners held 19,888 shares of Qiagen worth $653K as of Q4 2017.
  • AHL Partners sold 99,716 Qiagen shares in Q4 2017, an estimated $3.44M.
  • Qiagen made up 0.01% of AHL Partners's portfolio in Q4 2017, its #1013 holding.
  • AHL Partners first reported a position in Qiagen in Q1 2017 and has held it in 4 quarters since.
  • AHL Partners's Qiagen position peaked at $4M in Q3 2017.
  • 215 funds tracked by Wall St. Rank held Qiagen as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.